|
1
|
Sand M, Bechara FG, Sand D, Gambichler T,
Hahn SA, Bromba M, Stockfleth E and Hessam S: Expression profiles
of long noncoding RNAs in cutaneous squamous cell carcinoma.
Epigenomics. 8:501–518. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ouellet DL, Perron MP, Gobeil LA, Plante P
and Provost P: MicroRNAs in gene regulation: when the smallest
governs it all. J Biomed Biotechnol. 2006:696162006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Merritt WM, Lin YG, Han LY, Kamat AA,
Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick
AM, et al: Dicer, Drosha, and outcomes in patients with ovarian
cancer. N Engl J Med. 359:2641–2650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Melo SA, Moutinho C, Ropero S, Calin GA,
Rossi S, Spizzo R, Fernandez AF, Davalos V, Villanueva A, Montoya
G, et al: A genetic defect in exportin-5 traps precursor microRNAs
in the nucleus of cancer cells. Cancer Cell. 18:303–315. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Melo SA, Ropero S, Moutinho C, Aaltonen
LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F,
Oliveira C, et al: A TARBP2 mutation in human cancer impairs
microRNA processing and DICER1 function. Nat Genet. 41:365–370.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hill DA, Ivanovich J, Priest JR, Gurnett
CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wikenheiser-Brokamp
KA, Suarez BK, Whelan AJ, et al: DICER1 mutations in familial
pleuropulmonary blastoma. Science. 325:9652009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Torrezan GT, Ferreira EN, Nakahata AM,
Barros BD, Castro MT, Correa BR, Krepischi AC, Olivieri EH, Cunha
IW, Tabori U, et al: Recurrent somatic mutation in DROSHA induces
microRNA profile changes in Wilms tumour. Nat Commun. 5:40392014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar MS, Lu J, Mercer KL, Golub TR and
Jacks T: Impaired microRNA processing enhances cellular
transformation and tumorigenesis. Nat Genet. 39:673–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giannakakis A, Sandaltzopoulos R, Greshock
J, Liang S, Huang J, Hasegawa K, Li C, O'Brien-Jenkins A, Katsaros
D, Weber BL, et al: miR-210 links hypoxia with cell cycle
regulation and is deleted in human epithelial ovarian cancer.
Cancer Biol Ther. 7:255–264. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang L, Volinia S, Bonome T, Calin GA,
Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K,
et al: Genomic and epigenetic alterations deregulate microRNA
expression in human epithelial ovarian cancer. Proc Natl Acad Sci
USA. 105:7004–7009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sampath D, Liu C, Vasan K, Sulda M,
Puduvalli VK, Wierda WG and Keating MJ: Histone deacetylases
mediate the silencing of miR-15a, miR-16, and miR-29b in chronic
lymphocytic leukemia. Blood. 119:1162–1172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calin GA, Ferracin M, Cimmino A, Di Leva
G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et
al: A microRNA signature associated with prognosis and progression
in chronic lymphocytic leukemia. N Engl J Med. 353:1793–1801. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang W, Chendrimada TP, Wang Q, Higuchi M,
Seeburg PH, Shiekhattar R and Nishikura K: Modulation of microRNA
processing and expression through RNA editing by ADAR deaminases.
Nat Struct Mol Biol. 13:13–21. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang CH, Qiu J, O'Sullivan D, Buck MD,
Noguchi T, Curtis JD, Chen Q, Gindin M, Gubin MM, van der Windt GJ,
et al: Metabolic competition in the tumor microenvironment is a
driver of cancer progression. Cell. 162:1229–1241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang G, Nishimoto K, Zhou Z, Hughes D and
Kleinerman ES: miR-20a encoded by the miR-17-92 cluster increases
the metastatic potential of osteosarcoma cells by regulating Fas
expression. Cancer Res. 72:908–916. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong L, Lai M, Chen M, Xie C, Liao R, Kang
YJ, Xiao C, Hu WY, Han J and Sun P: The miR-17-92 cluster of
microRNAs confers tumorigenicity by inhibiting oncogene-induced
senescence. Cancer Res. 70:8547–8557. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY:
miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seike M, Goto A, Okano T, Bowman ED,
Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, et
al: MiR-21 is an EGFR-regulated anti-apoptotic factor in lung
cancer in never-smokers. Proc Natl Acad Sci USA. 106:12085–12090.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Özata DM, Caramuta S, Velázquez-Fernández
D, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C and
Lui WO: The role of microRNA deregulation in the pathogenesis of
adrenocortical carcinoma. Endocr Relat Cancer. 18:643–655. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J and Ma L: MicroRNA control of
epithelial-mesenchymal transition and metastasis. Cancer Metastasis
Rev. 31:653–662. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yao Q, Cao S, Li C, Mengesha A, Kong B and
Wei M: Micro-RNA-21 regulates TGF-β-induced myofibroblast
differentiation by targeting PDCD4 in tumor-stroma interaction. Int
J Cancer. 128:1783–1792. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eis PS, Tam W, Sun L, Chadburn A, Li Z,
Gomez MF, Lund E and Dahlberg JE: Accumulation of miR-155 and BIC
RNA in human B cell lymphomas. Proc Natl Acad Sci USA.
102:3627–3632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie Y, Todd NW, Liu Z, Zhan M, Fang H,
Peng H, Alattar M, Deepak J, Stass SA and Jiang F: Altered miRNA
expression in sputum for diagnosis of non-small cell lung cancer.
Lung Cancer. 67:170–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ovcharenko D, Kelnar K, Johnson C, Leng N
and Brown D: Genome-scale microRNA and small interfering RNA
screens identify small RNA modulators of TRAIL-induced apoptosis
pathway. Cancer Res. 67:10782–10788. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kong W, He L, Richards EJ, Challa S, Xu
CX, Permuth-Wey J, Lancaster JM, Coppola D, Sellers TA, Djeu JY, et
al: Upregulation of miRNA-155 promotes tumour angiogenesis by
targeting VHL and is associated with poor prognosis and
triple-negative breast cancer. Oncogene. 33:679–689. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Robertson ED, Wasylyk C, Ye T, Jung AC and
Wasylyk B: The oncogenic MicroRNA Hsa-miR-155-5p targets the
transcription factor ELK3 and links it to the hypoxia response.
PLoS One. 9:e1130502014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Calin GA, Liu CG, Sevignani C, Ferracin M,
Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, et al:
MicroRNA profiling reveals distinct signatures in B cell chronic
lymphocytic leukemias. Proc Natl Acad Sci USA. 101:11755–11760.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bandi N, Zbinden S, Gugger M, Arnold M,
Kocher V, Hasan L, Kappeler A, Brunner T and Vassella E: miR-15a
and miR-16 are implicated in cell cycle regulation in a
Rb-dependent manner and are frequently deleted or down-regulated in
non-small cell lung cancer. Cancer Res. 69:5553–5559. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Porkka KP, Ogg EL, Saramäki OR, Vessella
RL, Pukkila H, Lähdesmäki H, van Weerden WM, Wolf M, Kallioniemi
OP, Jenster G, et al: The miR-15a-miR-16-1 locus is homozygously
deleted in a subset of prostate cancers. Genes Chromosomes Cancer.
50:499–509. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bonci D, Coppola V, Musumeci M, Addario A,
Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C,
et al: The miR-15a-miR-16-1 cluster controls prostate cancer by
targeting multiple oncogenic activities. Nat Med. 14:1271–1277.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Patterson EE, Holloway AK, Weng J, Fojo T
and Kebebew E: MicroRNA profiling of adrenocortical tumors reveals
miR-483 as a marker of malignancy. Cancer. 117:1630–1639. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang Z, Sun H, Dai H, Walsh RM, Imakura
M, Schelter J, Burchard J, Dai X, Chang AN, Diaz RL, et al:
MicroRNA miR-210 modulates cellular response to hypoxia through the
MYC antagonist MNT. Cell Cycle. 8:2756–2768. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chabre O, Libé R, Assie G, Barreau O,
Bertherat J, Bertagna X, Feige JJ and Cherradi N: Serum miR-483-5p
and miR-195 are predictive of recurrence risk in adrenocortical
cancer patients. Endocr Relat Cancer. 20:579–594. 2013.PubMed/NCBI
|
|
40
|
Caramuta S, Lee L, Ozata DM, Akçakaya P,
Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C and Lui WO:
Clinical and functional impact of TARBP2 over-expression in
adrenocortical carcinoma. Endocr Relat Cancer. 20:551–564. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis
JW, Sun Y, Chen C, Guenther S, Sherlock J, Veltman I, Baeten J, et
al: High-throughput microRNAome analysis in human germ cell
tumours. J Pathol. 213:319–328. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gu S, Cheung HH, Lee TL, Lu G, Poon WS and
Chan WY: Molecular mechanisms of regulation and action of
microRNA-199a in testicular germ cell tumor and glioblastomas. PLoS
One. 8:e839802013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kiuchi T, Koga H, Kawamoto M, Shoji K,
Sakai H, Arai Y, Ishihara G, Kawaoka S, Sugano S, Shimada T, et al:
A single female-specific piRNA is the primary determiner of sex in
the silkworm. Nature. 509:633–636. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gou LT, Dai P, Yang JH, Xue Y, Hu YP, Zhou
Y, Kang JY, Wang X, Li H, Hua MM, et al: Pachytene piRNAs instruct
massive mRNA elimination during late spermiogenesis. Cell Res.
24:680–700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rouget C, Papin C, Boureux A, Meunier AC,
Franco B, Robine N, Lai EC, Pelisson A and Simonelig M: Maternal
mRNA deadenylation and decay by the piRNA pathway in the early
Drosophila embryo. Nature. 467:1128–1132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Qiao D, Zeeman AM, Deng W, Looijenga LH
and Lin H: Molecular characterization of hiwi, a human member of
the piwi gene family whose overexpression is correlated to
seminomas. Oncogene. 21:3988–3999. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Suzuki R, Honda S and Kirino Y: PIWI
expression and function in cancer. Front Genet. 3:2042012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sun G, Wang Y, Sun L, Luo H, Liu N, Fu Z
and You Y: Clinical significance of Hiwi gene expression in
gliomas. Brain Res. 1373:183–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hashim A, Rizzo F, Marchese G, Ravo M,
Tarallo R, Nassa G, Giurato G, Santamaria G, Cordella A, Cantarella
C, et al: RNA sequencing identifies specific PIWI-interacting small
non-coding RNA expression patterns in breast cancer. Oncotarget.
5:9901–9910. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chu H, Hui G, Yuan L, Shi D, Wang Y, Du M,
Zhong D, Ma L, Tong N, Qin C, et al: Identification of novel piRNAs
in bladder cancer. Cancer Lett. 356:561–567. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yan H, Wu QL, Sun CY, Ai LS, Deng J, Zhang
L, Chen L, Chu ZB, Tang B, Wang K, et al: piRNA-823 contributes to
tumorigenesis by regulating de novo DNA methylation and
angiogenesis in multiple myeloma. Leukemia. 29:196–206. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ravo M, Cordella A, Rinaldi A, Bruno G,
Alexandrova E, Saggese P, Nassa G, Giurato G, Tarallo R, Marchese
G, et al: Small non-coding RNA deregulation in endometrial
carcinogenesis. Oncotarget. 6:4677–4691. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cheng J, Deng H, Xiao B, Zhou H, Zhou F,
Shen Z and Guo J: piR-823, a novel non-coding small RNA,
demonstrates in vitro and in vivo tumor suppressive activity in
human gastric cancer cells. Cancer Lett. 315:12–17. 2012.
View Article : Google Scholar : PubMed/NCBI
|
